SOD1-ALS-Browser: a web-utility for investigating the clinical phenotype in SOD1 amyotrophic lateral sclerosis

References

• Shatunov A, Al-Chalabi A. The genetic architecture of ALS. Neurobiol Dis. 2021; 147:105156.
   PubMed Web of Science ®Google Scholar
• Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009; 10:310–23.
   PubMed Web of Science ®Google Scholar
• Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 1997; 48:55–7.
   PubMed Web of Science ®Google Scholar
• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013; 9:617–28.
   PubMed Web of Science ®Google Scholar
• Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol. 2012; 11:232–40.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, van der Spek RAA, Bakker MK, van Vugt JJFA, Hop PJ, Zwamborn RAJ, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021; 53:1636–48.
   PubMed Web of Science ®Google Scholar
• Umoh ME, Fournier C, Li Y, Polak M, Shaw L, Landers JE, et al. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology 2016; 87:1024–30.
   PubMed Web of Science ®Google Scholar
• Murphy NA, Arthur KC, Tienari PJ, Houlden H, Chio A, Traynor BJ. Age-related penetrance of the C9orf72 repeat expansion. Sci Rep. 2017; 7:2116.
   PubMed Web of Science ®Google Scholar
• Kalia M, Miotto M, Ness D, et al. Molecular dynamics analysis of superoxide dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression. bioRxiv 2022. doi: https://doi.org/10.1101/2022.12.05.519128
   Google Scholar
• Opie-Martin S, Iacoangeli A, Topp SD, Abel O, Mayl K, Mehta PR, et al. The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration. Nat Commun. 2022; 13:6901.
   PubMed Web of Science ®Google Scholar
• Bunton-Stasyshyn RKA, Saccon RA, Fratta P, Fisher EMC. SOD1 function and its implications for amyotrophic lateral sclerosis pathology:new and renascent themes. Neuroscientist. 2015; 21:519–29.
   PubMed Web of Science ®Google Scholar
• McCann EP, Williams KL, Fifita JA, Tarr IS, O”Connor J, Rowe DB, et al. The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet. 2017; 92:259–66.
   PubMed Web of Science ®Google Scholar
• Parton MJ, Broom W, Andersen PM, Al-Chalabi A, Nigel Leigh P, Powell JF, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat. 2002; 20:473.
   PubMed Web of Science ®Google Scholar
• Bali T, Self W, Liu J, Siddique T, Wang LH, Bird TD, et al. Defining SOD1 ALS natural history to guide therapeutic clinical trial design. J Neurol Neurosurg Psychiatry. 2017; 88:99–105.
   PubMed Web of Science ®Google Scholar
• Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2022; 387:1099–110.
   PubMed Web of Science ®Google Scholar
• IUPAC-IUB. Joint commission on biochemical nomenclature. Nomenclature and symbolism for amino acids and peptides: recommendations 1983. Eur J Biochem 1984; 138:9–37.
   PubMedGoogle Scholar
• Attali D. shinyjs: easily improve the user experience of your shiny apps in seconds. 2020. R package version 2.1.0. Available from: https://CRAN.R-project.org/package=shinyjs
   Google Scholar
• Chang W, Cheng J, Allaire J, et al. shiny: web application framework for R. 2022. R package version 1.7.4. Available from: https://CRAN.R-project.org/package=shiny
   Google Scholar
• R Core Team. R: A language and environment for statistical computing. 2021. Vienna, Austria: R Foundation for Statistical Computing,. Available from: https://www.R-project.org/
   Google Scholar
• Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, et al. Welcome to the Tidyverse. Joss. 2019; 4:1686.
   Google Scholar
• Allaire J, Xie Y, McPherson J, et al. rmarkdown: dynamic documents for R. 2022. R package version 2.21. Available from: https://rmarkdown.rstudio.com
   Google Scholar
• Arel-Bundock V, Enevoldsen N, Yetman C. Countrycode: an R package to convert country names and country codes. Joss. 2018; 3:848.
   Google Scholar
• Zhu H. kableExtra: construct complex Table with “kable” and Pipe Syntax. 2021. R package version 1.3.4. Available from: https://CRAN.R-project.org/package=kableExtra
   Google Scholar
• Sievert C. Interactive web-based data visualization with R, plotly, and shiny. Florida: CRC Press; 2020.
   Google Scholar
• Sali A, Attali D. shinycssloaders: Add Loading Animations to a “shiny” Output While It”s Recalculating. 2020. R package version 1.0.0. Available from: https://CRAN.R-project.org/package=shinycssloaders
   Google Scholar
• Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using “ggplot2”. 2021. 0.4.9. Available from: https://CRAN.R-project.org/package=survminer
   Google Scholar
• Therneau T. A Package for Survival Analysis in R. 2023. 3.5-5. Available from: https://CRAN.R-project.org/package=survival
   Google Scholar
• Sharer JD. Amino Acid Disorders. In: Aminoff MJ, Daroff RB, eds. Encyclopedia of the Neurological Sciences. Second Edition. Oxford: Academic Press; 2014. p. 136–47.
   Google Scholar
• Tompa DR, Kadhirvel S. Changes in hydrophobicity mainly promotes the aggregation tendency of ALS associated SOD1 mutants. Int J Biol Macromol. 2020; 145:904–13.
   PubMed Web of Science ®Google Scholar
• Cordes MHJ, Sauer RT. Tolerance of a protein to multiple polar-to-hydrophobic surface substitutions. Protein Sci. 2008; 8:318–25.
   Google Scholar
• Gidalevitz T, Krupinski T, Garcia S, Morimoto RI. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLOS Genet. 2009; 5:e1000399.
   PubMed Web of Science ®Google Scholar
• Dyson HJ, Wright PE, Scheraga HA. The role of hydrophobic interactions in initiation and propagation of protein folding. Proc Natl Acad Sci U S A. 2006; 103:13057–61.
   PubMed Web of Science ®Google Scholar
• Park JH, Elpers C, Reunert J, McCormick ML, Mohr J, Biskup S, et al. SOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis. Brain. 2019; 142:2230–7.
   PubMed Web of Science ®Google Scholar
• Ezer S, Daana M, Park JH, Yanovsky-Dagan S, Nordström U, Basal A, et al. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity. Brain. 2022; 145:872–8.
   PubMed Web of Science ®Google Scholar
• Farrimond L, Talbot K. A case of SOD1 deficiency: implications for clinical trials. Brain. 2022; 145:805–6.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020; 581:434–43.
   PubMed Web of Science ®Google Scholar
• Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat. 2012; 33:1345–51.
   PubMed Web of Science ®Google Scholar
• King”s College London. King”s computational research, engineering and technology environment (CREATE) 2022 [October 12 2022]. Available from: https://doi.org/10.18742/rnvf-m076
   Google Scholar